Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
02/2004
02/25/2004CN1477199A A polypeptide-human phosphatidase 14 and polynucleotide for coding said polypeptide
02/25/2004CN1477198A A polypeptide-human RNA uncoiling enzyme 44 and polynucleotide for coding said polypeptide
02/25/2004CN1477196A A polypeptide-CoA carboxylase 41 and polynucleotide for coding said polypeptide
02/25/2004CN1477195A A polypeptide-human methionyl-tRNA synthetase 29 and polynucleotide for coding said polypeptide
02/25/2004CN1477194A A polypeptide-human transpasase 105 and polynucleotide coding said polypetide
02/25/2004CN1477193A Novel human Rab GTP enzyme, its coding sequence and application
02/25/2004CN1477128A Preparation method of specific IgY for resisting respiratory tract infection and its compound preparation
02/25/2004CN1477127A Anti-venerism specific compound vitelline antibody and its application for curing venerism
02/25/2004CN1477125A A polypeptide-human amelification protein 23 and polynucleotide for coding said polypeptide
02/25/2004CN1477124A A polypeptide-zinc finger protein 42 and polynucleotide for coding said polypeptide
02/25/2004CN1477123A A polypeptide-transcription factor 43 and polynucleotide coding said polypeptide
02/25/2004CN1477122A A polypeptide-human blood vessel epithelial calcium adhesion protein 54 and polynuceotide for coding said polypeptide
02/25/2004CN1477121A A polypeptide-human ankyrin 27 and polynucleotide coding said polypeptide
02/25/2004CN1477120A A polypeptide-human tissue anion transport polypeptide 41 and polynucleotide coding said polypeptide
02/25/2004CN1477119A Novel Human cysteine proteinase inhibitor sample molecule, its coding sequence and application
02/25/2004CN1477118A Novel DnaJ/Hsp40 molecule DC-DJIII, its coding sequence and application
02/25/2004CN1477117A Novel human phosphotidylethanolamine binding protein, its coding sequence and application
02/25/2004CN1477116A Novel human secretion-related membrane protion, its coding sequence and its application
02/25/2004CN1477115A Novel human cyclin, its coding sequence and application
02/25/2004CN1477114A Immunoglobulin sample receptor originated from human dendritic cell, its coding sequence and application
02/24/2004USRE38446 Sucrose phosphate synthase (SPS), its process for preparation its cDNA, and utilization of cDNA to modify the expression of SPS in plant cells
02/24/2004US6696620 Immunoglobulin binding protein arrays in eukaryotic cells
02/24/2004US6696557 Isolated nucleic acid comprising nucleotide sequence encoding extracellular domain of al-2 fused to immunoglobulin amino acid sequence
02/24/2004US6696550 Humanized anti-CCR2 antibodies and methods of use therefor
02/24/2004US6696548 An isolated nucleic acid encoding a polypeptide wherein the polypeptide has tyrosine kinase activity and renders an interleukin-3-dependent lymphoid cell line factor independent
02/24/2004US6696547 Mutant DEDD proteins for regulating apoptosis
02/24/2004US6696493 Treating chronic uremic patients undergoing periodic dialysis
02/24/2004US6696280 Polypeptide for use in the diagnosis, prevention and treatment of fungal infections
02/24/2004US6696279 Modulating methionine adenosyltransferase ii (mat ii) catalytic activity
02/24/2004US6696273 FEBP1 Protein: vector, host cells and method for making FEBP1 protein
02/24/2004US6696263 PCNA associated cell cycle proteins, compositions and methods of use
02/24/2004US6696257 G protein-coupled receptors from the rat and human
02/24/2004US6696254 Detection and identification of enteric bacteria
02/24/2004US6696248 Protein/(poly)peptide libraries
02/24/2004US6696245 Methods for selecting functional polypeptides
02/24/2004US6696062 BASB006 polypeptides from Neisseria meningitidis and immunogenic compositions thereof
02/24/2004US6696060 Methods for sterilizing preparations of monoclonal immunoglobulins
02/24/2004CA2132213C Specific detection of cell surface receptor leukocyte adhesion molecule-1
02/24/2004CA2102036C Vaccines raising an immunological response against the disease caused by the iowa strain of porcine reproductive and respiratory syndrome virus
02/19/2004WO2004015109A1 Human acid sensing ion channel 2b (hasic2b), process for producing the same, and its use
02/19/2004WO2004015057A2 Mucin-immunoglobulin fusion proteins
02/19/2004WO2004014955A1 Anti-idiotypic antibodies against factor viii inhibitor and uses thereof
02/19/2004WO2004014954A1 Exosome containing exogenous antigen through gene transfection and method for utilizing the same
02/19/2004WO2004014953A2 Anti-myelin associated glycoprotein (mag) antibodies
02/19/2004WO2004014952A2 Specific probnp(1-108) antibodies for diagnosing heart failure
02/19/2004WO2004014423A1 Methods for the treatment of an infectious bacterial disease with an anti-lactone or lactone derived signal molecules antibody
02/19/2004WO2004014422A1 A method of immunomodulation
02/19/2004WO2004014421A1 Use of antibodies against a tumor-associated antigen
02/19/2004WO2004014420A1 Pharmaceutical compositions comprising an hiv envelope protein and cd4
02/19/2004WO2004014311A2 Nogo receptor antagonists
02/19/2004WO2004014292A2 EphA2 AGONISTIC MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF
02/19/2004WO2003106697A3 Method and kit for identifying pseudomonas aeruginosa
02/19/2004WO2003104812A3 DIAGNOSIS OF ALZHEIMER'S DISEASE BASED ON THE hAbeta42:hAbeta40 RATIO
02/19/2004WO2003102584A3 Semaphorin-like proteins and methods of using same
02/19/2004WO2003100429A3 Diagnosis of hepatocellular carcinoma
02/19/2004WO2003099193A3 Vaccines
02/19/2004WO2003088979A3 Oligonucleotides from sequences coding for the surface component of envelope proteins of primate t-cell leukaemia/lymphoma viruses (ptlv) and uses thereof
02/19/2004WO2003086310A3 Prevention of brain inflammation as a result of induced autoimmune response
02/19/2004WO2003085124A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
02/19/2004WO2003080640B1 Lymphatic and blood endothelial cell genes
02/19/2004WO2003072803A3 Nanostructures containing antibody assembly units
02/19/2004WO2003059251A3 Antibody targeting compounds
02/19/2004WO2003054016A3 Method for cloning of variable domain sequences
02/19/2004WO2003050265A3 Compositions and methods for normalizing assays
02/19/2004WO2003048384A3 Methods of identifying genetic risk for and evaluating treatment of alzheimer's disease by determing single nucleotide polymorphisms
02/19/2004WO2003048317A9 Antibodies to magmas and uses thereof
02/19/2004WO2003048193A3 GIPs, A FAMILY OF POLYPEPTIDES WITH TRANSCRIPTION FACTOR ACTIVITY THAT INTERACT WITH GOODPASTURE ANTIGEN BINDING PROTEIN
02/19/2004WO2003046571A3 Hp and apolipoprotein biopolymer markers predictive of alzheimers disease
02/19/2004WO2003046564A3 Protein biopolymer markers predictive of alzheimers disease
02/19/2004WO2003040341A3 Anti-hepatitis a virus antibodies
02/19/2004WO2003020212A3 Treatment for central nervous system disorders
02/19/2004WO2003016904A3 Peptide sequence tags and method of using same
02/19/2004WO2003016352A8 Monoclonal antibodies against fungi and methods for their use
02/19/2004WO2003014731A3 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use
02/19/2004WO2003010291A3 Treatment of immune disorders and b cell disorders
02/19/2004WO2003008537A9 Epitope sequences
02/19/2004WO2003004532A3 Q9ul33/q9nzz4 and q9h5p3 splice variants
02/19/2004WO2003000113A9 Compositions and methods for the diagnosis and treatment of tumor
02/19/2004WO2002088185A3 Pan-specific monoclonal antibody
02/19/2004WO2002088184A9 A molecular marker
02/19/2004WO2002083866A3 Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions
02/19/2004WO2002081496A3 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours
02/19/2004WO2002078613A3 Immunoglobulin construct containing anti-mucin variable domain sequences for eliciting an anti-idiotype anti-tumor response
02/19/2004WO2002074251A3 Monoclonal antibody therapy for pancreas cancer
02/19/2004WO2002061086A3 Human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1
02/19/2004WO2002055726A3 Detection and alteration of mhc class ii presentation phenotypes
02/19/2004WO2002048337A3 Secreted human proteins
02/19/2004WO2002046477A3 Endogenous retroviruses up-regulated in prostate cancer
02/19/2004WO2002028888A3 Mimotope of neisseria meningitides lipooligosaccharide and vaccines containing the same
02/19/2004US20040034881 Comprises rodent containing mutation in programmed cell death-1 receptor (PD-1) gene for use as animal model in diagnosis and treatment of dilated cardiomyopathy
02/19/2004US20040034199 Human pellino polypeptides
02/19/2004US20040033974 Use of genes identified to be involved in tumor development for the development of anti-cancer drugs
02/19/2004US20040033566 Genetically engineered serine protease for diagnosis and treatment of blood disorders
02/19/2004US20040033565 Isolated human G-Protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof
02/19/2004US20040033561 Immunoglobulin DNA cassette molecules, monobody constructs, methods of production, and methods of use therefor
02/19/2004US20040033560 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/19/2004US20040033559 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/19/2004US20040033558 Secreted and transmembrane polypeptides and nucleic acids encoding the same
02/19/2004US20040033544 Polyclonal antibodies against fibrinogen degradation products and associated methods of production and use
02/19/2004US20040033543 Using monoclonal antibodies with affinity binding to epidermal growth factor receptors to treat kidney tumors; antitumor agents; immunotherapy